Dafne Müller - Concepedia

Author

Dafne Müller

University of Stuttgart

Also Known As

D Muller, D Müller, D. Muller, D. Müller, D.P.R. Muller, Dafne Muller, Dafne Müller

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of Stuttgart Friedrich Schiller University Jena Friedrich-Alexander-Universität Erlangen-Nürnberg

About

Dafne Müller is an author at University of Stuttgart specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	886
2	Engineering	3	3	114
3	Biomedical Engineering	2	2	47
4	Health Sciences	1	1	26
5	Biochemistry	1	1	96

Dafne Müller

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Improved Pharmacokinetics of Recombinant Bispecific Antibody Molecules by Fusion to Human Serum Albumin Dafne Müller, Anette Karle, Bettina Meißburger, Journal of Biological Chemistry Single Chain DiabodiesImmunocytochemical TechniqueTandem Scfv MoleculesMedicineImmunology	2007	216
A novel tri-functional antibody fusion protein with improved pharmacokinetic properties generated by fusing a bispecific single-chain diabody with an albumin-binding domain from streptococcal protein G Roland Stork, Dafne Müller, Roland E. Kontermann Protein Engineering Design and Selection	2007	111
Biodistribution of a Bispecific Single-chain Diabody and Its Half-life Extended Derivatives Roland Stork, Emmanuelle Campigna, Bruno Robert, Journal of Biological Chemistry	2009	104
N-Glycosylation as Novel Strategy to Improve Pharmacokinetic Properties of Bispecific Single-chain Diabodies Roland Stork, Kirstin A. Zettlitz, Dafne Müller, Journal of Biological Chemistry Pharmaceutical ScienceImprove Pharmacokinetic PropertiesGlycobiologyImmunologyBispecific Single-chain Diabodies	2008	96
The effects of affinity and valency of an albumin-binding domain (ABD) on the half-life of a single-chain diabody-ABD fusion protein Jane F Hopp, Nadine Hornig, Kirstin A. Zettlitz, Protein Engineering Design and Selection	2010	89
Recombinant bispecific antibodies for cellular cancer immunotherapy. Dafne Müller, Roland E. Kontermann PubMed Tumor BiologyTumor ImmunologyCytotoxic Effector CellsMedicineImmunology	2007	83
miR149 Functions as a Tumor Suppressor by Controlling Breast Epithelial Cell Migration and Invasion Annabell Bischoff, Bettina Huck, Bettina G. Keller, Cancer Research	2014	75
Generation of a FasL-based Proapoptotic Fusion Protein Devoid of Systemic Toxicity due to Cell-surface Antigen-restricted Activation Dierk Samel, Dafne Müller, Jeannette Gerspach, Journal of Biological Chemistry	2003	73
Targeted delivery of SiRNA to CD33-positive tumor cells with liposomal carrier systems Miriam Rothdiener, Dafne Müller, Patricia Garrido Castro, Journal of Controlled Release Cell-based Drug DeliveryNanomedicineLiposomal Carrier SystemsImmunologyTargeted Drug Delivery	2010	57
Targeting of Epidermal Growth Factor Receptor (EGFR)-Expressing Tumor Cells with Sterically Stabilized Affibody Liposomes (SAL) Julia Beuttler, Miriam Rothdiener, Dafne Müller, Bioconjugate Chemistry EngineeringAffibody MoleculesTumor CellsExtracellular MicrovesiclesAffibody Liposomes	2009	52

Page 1